Correlation Between Akoya Biosciences and Repro Med

Can any of the company-specific risk be diversified away by investing in both Akoya Biosciences and Repro Med at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akoya Biosciences and Repro Med into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Akoya Biosciences and Repro Med Systems, you can compare the effects of market volatilities on Akoya Biosciences and Repro Med and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akoya Biosciences with a short position of Repro Med. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akoya Biosciences and Repro Med.

Diversification Opportunities for Akoya Biosciences and Repro Med

0.78

Correlation Coefficient

Akoya Biosciences  Repro Med

Poor diversification

The 3 months correlation between Akoya and Repro is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Akoya Biosciences and Repro Med Systems in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Repro Med Systems and Akoya Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akoya Biosciences are associated (or correlated) with Repro Med. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Repro Med Systems has no effect on the direction of Akoya Biosciences i.e., Akoya Biosciences and Repro Med go up and down completely randomly.

Pair Corralation between Akoya Biosciences and Repro Med

Given the investment horizon of 90 days Akoya Biosciences is expected to under-perform the Repro Med. In addition to that, Akoya Biosciences is 1.18 times more volatile than Repro Med Systems. It trades about -0.14 of its total potential returns per unit of risk. Repro Med Systems is currently generating about -0.15 per unit of volatility. If you would invest  389.00  in Repro Med Systems on December 28, 2024 and sell it today you would lose (128.00) from holding Repro Med Systems or give up 32.9% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Akoya Biosciences  vs.  Repro Med Systems

Akoya Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Akoya Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Repro Med Systems

Risk-Adjusted Performance

Very Weak

Over the last 90 days Repro Med Systems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Akoya Biosciences and Repro Med

The main advantage of trading using opposite Akoya Biosciences and Repro Med positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akoya Biosciences position performs unexpectedly, Repro Med can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Repro Med will offset losses from the drop in Repro Med's long position.

The idea behind Akoya Biosciences and Repro Med Systems pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.